GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (STU:A71) » Definitions » Accounts Payable

Ascendis Pharma AS (STU:A71) Accounts Payable : €84.4 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Ascendis Pharma AS Accounts Payable?

Ascendis Pharma AS's Accounts Payable for the quarter that ended in Mar. 2025 was €84.4 Mil.

Ascendis Pharma AS's quarterly Accounts Payable increased from Sep. 2024 (€75.3 Mil) to Dec. 2024 (€96.4 Mil) but then declined from Dec. 2024 (€96.4 Mil) to Mar. 2025 (€84.4 Mil).

Ascendis Pharma AS's annual Accounts Payable declined from Dec. 2022 (€101.0 Mil) to Dec. 2023 (€94.6 Mil) but then increased from Dec. 2023 (€94.6 Mil) to Dec. 2024 (€96.4 Mil).

Ascendis Pharma AS Accounts Payable Historical Data

The historical data trend for Ascendis Pharma AS's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Accounts Payable Chart

Ascendis Pharma AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.90 59.42 101.03 94.57 96.39

Ascendis Pharma AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.53 99.53 75.27 96.39 84.37

Ascendis Pharma AS Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Ascendis Pharma AS Accounts Payable Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (STU:A71) » Definitions » Accounts Payable
Comparable Companies
MRNA BMRN CORT EXEL ROIV RVMD TECH INSM INCY HALO VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ASND:USA A71:Germany A1SN34:Brazil
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Website
https://www.ascendispharma.com
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Ascendis Pharma AS Headlines

No Headlines